Elizabeth Garcia
About Elizabeth Garcia
Elizabeth Garcia, PhD - Title and Current Role
Elizabeth Garcia, PhD, holds the position of Vice President of Lab Operations. With over 20 years of experience in developing diagnostic assays, she plays a key role in managing and overseeing lab operations, ensuring that diagnostic procedures are both accurate and efficient.
Elizabeth Garcia, PhD - Education and Expertise
Elizabeth Garcia, PhD, earned her doctoral degree in Molecular and Cellular Biology from the University of Maryland. Her extensive expertise in molecular techniques has been honed over two decades in various startup, academic, and industry settings. Her early focus was on neurobiology, conducting research at the HHMI Yale University and Sention, which led to the development of novel molecular screening methods.
Elizabeth Garcia, PhD - Professional Background
Elizabeth Garcia, PhD, has held significant positions in the healthcare and diagnostics industry. She co-founded Primera Diagnostics, a diagnostic company utilizing proprietary technologies. Prior to her current role at Variantyx, she served as the Director of Assay Development at the same company. She also held the position of Associate Director at the Dana-Farber Cancer Institute/Brigham and Women's Hospital, where she was instrumental in launching high throughput genomic assays aimed at profiling tumors for personalized cancer treatment.
Elizabeth Garcia, PhD - Achievements in Assay Development
During her tenure at Dana-Farber Cancer Institute/Brigham and Women's Hospital, Elizabeth Garcia, PhD, launched clinical high throughput genomic assays. This initiative aimed to molecularly profile all tumors presented at DFCI, BWH, and Boston Children's Hospital. As a result, a comprehensive cancer database with over 30,000 patient profiles linked with clinical information was developed, significantly contributing to the field of personalized cancer medicine.